Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.

Zhang Y, Wang J, Wang Y, Lu XC, Fan H, Liu Y, Zhang Y, Feng KC, Zhang WY, Chen MX, Fu X, Han WD.

Clin Dev Immunol. 2013;2013:195691. doi: 10.1155/2013/195691. Epub 2013 Dec 9.

PMID:
24382970
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Update on vaccine development for renal cell cancer.

Chi N, Maranchie JK, Appleman LJ, Storkus WJ.

Open Access J Urol. 2010 Aug 4;2:125-41. Review.

PMID:
24198621
[PubMed]
Free PMC Article
3.

UPDATE ON VACCINE DEVELOPMENT FOR RENAL CELL CANCER.

Chi N, Maranchie JK, Appleman LJ, Storkus WJ.

Open Access J Urol. 2010 Aug;2010(2):125-141.

PMID:
23843712
[PubMed]
Free PMC Article
4.

Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.

Flörcken A, Kopp J, van Lessen A, Movassaghi K, Takvorian A, Jöhrens K, Möbs M, Schönemann C, Sawitzki B, Egerer K, Dörken B, Pezzutto A, Westermann J.

Hum Vaccin Immunother. 2013 Jun;9(6):1217-27. doi: 10.4161/hv.24149. Epub 2013 Mar 4.

PMID:
23458999
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination.

Pohla H, Buchner A, Stadlbauer B, Frankenberger B, Stevanovic S, Walter S, Frank R, Schwachula T, Olek S, Kopp J, Willimsky G, Stief CG, Hofstetter A, Pezzutto A, Blankenstein T, Oberneder R, Schendel DJ.

Mol Med. 2013 Feb 8;18:1499-508. doi: 10.2119/molmed.2012.00221.

PMID:
23269976
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Trial watch: Dendritic cell-based interventions for cancer therapy.

Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 Oct 1;1(7):1111-1134.

PMID:
23170259
[PubMed]
Free PMC Article
7.

Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.

Koido S, Homma S, Takahara A, Namiki Y, Komita H, Nagasaki E, Ito M, Nagatsuma K, Uchiyama K, Satoh K, Ohkusa T, Gong J, Tajiri H.

J Biomed Biotechnol. 2011;2011:910836. doi: 10.1155/2011/910836. Epub 2011 Apr 26. Review.

PMID:
21541197
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunotherapy for renal cell carcinoma.

Itsumi M, Tatsugami K.

Clin Dev Immunol. 2010;2010:284581. doi: 10.1155/2010/284581. Epub 2011 Jan 3.

PMID:
21253521
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Regulation of tumor immunity by tumor/dendritic cell fusions.

Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H, Nagasaki E, Ito M, Ohkusa T, Gong J, Tajiri H.

Clin Dev Immunol. 2010;2010:516768. doi: 10.1155/2010/516768. Epub 2010 Oct 26. Review.

PMID:
21048993
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cancer vaccine by fusions of dendritic and cancer cells.

Koido S, Hara E, Homma S, Namiki Y, Ohkusa T, Gong J, Tajiri H.

Clin Dev Immunol. 2009;2009:657369. doi: 10.1155/2009/657369. Epub 2010 Feb 18. Review.

PMID:
20182533
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk